Systematic Review

Published on 10 Jan 2025

The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis

in Heart Valve Disease

Zhili Wei
Xinquan Shao
Zhijing An
Yixuan Chang
Shidong Liu
Ziran Luo
Yang Chen
Bing Song

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1489674

143 views

Review

Published on 08 Jan 2025

Evolving perspectives on aortic stenosis: the increasing importance of evaluating the right ventricle before aortic valve intervention

in Heart Valve Disease

Vitaliy Androshchuk
Omar Chehab
Joshua Wilcox
Benedict McDonaugh
Natalie Montarello
Ronak Rajani
Bernard Prendergast
Tiffany Patterson
Simon Redwood

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1506993

278 views

Review

Accepted on 02 Jan 2025

Progress on long non-coding RNAs in calcific aortic valve disease

in Heart Valve Disease

Yan Shen
Jiahui Li
Zehao Zhao
Xiaomin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1522544

Brief Research Report

Accepted on 26 Dec 2024

Epigallocatechin Gallate (EGCG) Modulates Senescent Endothelial Cell-Monocyte Communication in Age-Related Vascular Inflammation

in Heart Valve Disease

Sarvatit Patel
Kai Ellis
Corey A Scipione
Jason E. Fish
Kathryn L Howe

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1506360

Review

Published on 19 Dec 2024

Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease

in Heart Valve Disease

Enze Fu
Kai Pan
Zongjin Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1503830

531 views

Original Research

Published on 18 Dec 2024

The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery

in Heart Valve Disease

Natalia Pavone
Federico Cammertoni
Maria Calabrese
Piergiorgio Bruno
Giancarlo Scoppettuolo
Antonella Lombardo
Francesca Giovannenze
Eleonora Taddei
Barbara Fiori
Tiziana D’Inzeo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1504197

375 views

Original Research

Accepted on 13 Dec 2024

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair

in Heart Valve Disease

Johannes Kirchner
Muhammed Gerçek
Hazem Omran
Kai Friedrichs
Felix Rudolph
Tobias Rossnagel
Misagh Piran
Arseniy Goncharov
Maria Ivannikova
Volker Rudolph

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1463978

122 views

Case Report

Published on 09 Dec 2024

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

in Heart Valve Disease

Benjamin Mothibe Bussmann
Sam Dawkins
James Newton
Thomas Cahill

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1487061

519 views

Review

Published on 19 Nov 2024

The role of pre-existing left-sided valvular heart disease in the prognosis of patients with acute myocardial infarction

in Heart Valve Disease

Tamilla Muzafarova
Zuzana Motovska

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1465723

498 views

Review

Accepted on 31 Oct 2024

Rethinking Mechanical Heart Valves in the Aortic Position: New Paradigms in Design and Testing

in Heart Valve Disease

Sreyashi Chakraborty
Mindy Simon
Alessandro Bellofiore

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1458809

Original Research

Published on 21 Oct 2024

Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization

in Heart Valve Disease

Dominik Felbel
Juliana von Winkler
Michael Paukovitsch
Matthias Gröger
Elene Walther
Stefanie Andreß
Leonhard Schneider
Sinisa Markovic
Wolfgang Rottbauer
Mirjam Keßler

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1452446

646 views

Original Research

Published on 03 Oct 2024

Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study

in Heart Valve Disease

Yue Wang
Yusi Shen
Lina Tan
Liangbo Hu
Min He
Xiaocong Zeng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1404284

1,071 views

Original Research

Published on 26 Sep 2024

Higher serum phosphate within the normal range is associated with the development of calcified aortic valve disease

in Heart Valve Disease

Kyung An Kim
Hae-Ok Jung
Mi-Jeong Kim
So-Young Lee
Yuran Ahn
Mi-Hyang Jung
Woo-Baek Chung
Dong-Hyeon Lee
Ho-Joong Youn
Hyuk-Jae Chang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1450757

642 views

Original Research

Published on 24 Sep 2024

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway

in Heart Valve Disease

Qingzhou Yao
Erlinda The
Balachandar Nedumaran
Yufeng Zhai
Lihua Ao
David A. Fullerton
Xianzhong Meng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1410862

602 views

Review

Published on 02 Sep 2024

Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

in Heart Valve Disease

Dominika Bernáth-Nagy
Melek Sükran Kalinyaprak
Evangelos Giannitsis
Pál Ábrahám
Florian Leuschner
Norbert Frey
Jona Benjamin Krohn

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1425159

1,339 views

Original Research

Published on 29 Aug 2024

Ex vivo model of pathological calcification of human aortic valve

in Heart Valve Disease

O. S. Kachanova
N. V. Boyarskaya
P. M. Docshin
T. S. Scherbinin
V. G. Zubkova
V. L. Saprankov
V. E. Uspensky
L. B. Mitrofanova
A. B. Malashicheva

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1411398

1,102 views

Navigation group

Articles

The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis

Evolving perspectives on aortic stenosis: the increasing importance of evaluating the right ventricle before aortic valve intervention

Progress on long non-coding RNAs in calcific aortic valve disease

Epigallocatechin Gallate (EGCG) Modulates Senescent Endothelial Cell-Monocyte Communication in Age-Related Vascular Inflammation

Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease

The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

The role of pre-existing left-sided valvular heart disease in the prognosis of patients with acute myocardial infarction

Rethinking Mechanical Heart Valves in the Aortic Position: New Paradigms in Design and Testing

Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization

Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study

Higher serum phosphate within the normal range is associated with the development of calcified aortic valve disease

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway

Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

Ex vivo model of pathological calcification of human aortic valve